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Copyright © 2007 AHC N-acetylgalactosamine 4-sulfate 6-O-sulfotransferase (GalNAc4S-6ST) is a sulfotransferase
responsible for biosynthesis of chondroitin sulfate E (CS-E). CS-E plays important roles in
numerous biological events, such as neurite outgrowth. However, the role of GalNAc4S-6ST
in tumor progression remains unknown. In the present study, we analyzed expression of
GalNAc4S-6ST mRNA in colorectal cancer by combining real-time RT-PCR with in situ
hybridization (ISH) using archived formalin-fixed and paraffin-embedded tissue sections. In
57.5% of 40 patients, expression of GalNAc4S-6ST mRNA was increased in cancer tissues
compared with paired normal mucosa. ISH using an RNA probe specific for GalNAc4S-6ST
revealed that it was expressed in colorectal cancer cells. Analysis of the relationship
between expression of GalNAc4S-6ST as determined by real-time RT-PCR assay and var-
ious clinicopathological variables revealed that GalNAc4S-6ST was associated with vessel
invasion, although a statistically significant difference was not seen (P=0.125 for lymphatic
vessel invasion and P=0.242 for venous invasion). Taken together, we show that real-time
RT-PCR combined with ISH is useful to investigate quantitatively GalNAc4S-6ST mRNA ex-
pression in formalin-fixed and paraffin-embedded tissue sections, and that GalNAc4S-6ST
expressed by colorectal cancer cells plays a minor role in tumor progression.
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I. Introduction
Complex carbohydrates such as glycoproteins, glyco-
lipids, and proteoglycans present on the cell surface or
extracellular matrix play important roles in various bio-
logical events not only under physiological conditions but in
pathological states such as inflammation and tumor progres-
sion [6, 7, 21, 25]. Since attached glycans are synthesized by
concerted reactions of glycosyltransferases and sulfotrans-
ferases, the analysis of glycogenes, which encode these
glycosyltransferases and sulfotransferases, will be helpful
to understand the biological functions of glycan chains, as
shown in an example of the analysis of O-GlcNAc trans-
ferase in diabetic rats [1]. Approximately 180 human glyco-
genes have been cloned so far, and thus molecular and bio-
chemical information regarding their activity is available
[19]. However, the study of glycogenes at the mRNA level
using archived formalin-fixed and paraffin-embedded tissue
blocks for routine pathological examination has been limited
due to overall low expression of these transcripts [3].
Glycan chains comprising proteoglycans, called gly-
cosaminoglycans (GAG), are variably sulfated by specificIto et al. 54
sulfotransferases [8, 14]. Chondroitin sulfate (CS) is a typi-
cal GAG subtype, and the negatively charged nature of GAG
is implicated in several biological processes. In particular,
chondroitin sulfate E (CS-E), which is composed of repeat-
ing GlcAβ1-3GalNAc(4,6-bis-SO4) disaccharide units with
a β1,4-linkage and were originally identified in squid carti-
lage [10], has been reported to play diverse roles in vitro.
Among these are release of histamine from mast cells [5], in-
hibition of procoagulant activity [16], promotion of neural
outgrowth [2], and binding to heparin binding growth fac-
tors such as midkine and pleiotrophin [4, 26], basic fibro-
blast growth factors [4], E/P-selectin, and chemokines [11].
In addition, CS-E is known to be increased under pathologi-
cal conditions, such as liver cirrhosis developed in the Long-
Evans Cinnamon rat animal model of this disease [13]. In
tumors, Monzavi-Karbassi et al. demonstrated that CS-E
units inhibited P-selectin binding to a human breast cancer
cell line in vitro [17]. Since P-selectin (also called GMP-140
and PADGEM) is found within the Weibel-Palade bodies
of endothelial cells and α-granules of platelets [15], CS-E
on the tumor cells may facilitate the metastasis by binding
to P-selectin present in endothelial cells and/or platelets.
However, the clinicopathological significance of CS-E ex-
pression in tumors in vivo remains unknown.
Recently, we purified N-acetylgalactosamine 4-sulfate
6-O-sulfotransferase (GalNAc4S-6ST) protein from squid
cartilage [9] and subsequently cloned its human orthologue
[20]. GalNAc4S-6ST is responsible for the biosynthesis of
CS-E from chondroitin sulfate A (CS-A) by transferring a
sulfate group to the position C6 of GalNAc(4SO4) in CS-A
(Fig. 1). Since the specific antibody directed to CS-E has not
been available, analyses of GalNAc4S-6ST gene are helpful
to understand the biological roles of CS-E.
In the present study, we quantitatively analyzed expres-
sion of GalNAc4S-6ST mRNA detected in colorectal cancer
tissue sections prepared from archived formalin-fixed and
paraffin-embedded tissue blocks used for routine pathologi-
cal examination by real-time RT-PCR assay. Since real-time
RT-PCR assays cannot identify cell type(s) expressing a
specific mRNA, we also carried out in situ hybridization
(ISH) with a specific GalNAc4S-6ST RNA probe in the
same colorectal cancer tissues for comparison. Finally, to
determine a possible role of GalNAc4S-6ST in tumor pro-
gression, we compared expression levels of GalNAc4S-6ST
mRNA detected in colorectal cancer with clinicopathologi-
cal variables.
II. Materials and Methods
Patient samples
Formalin-fixed and paraffin-embedded tissue blocks
of surgically resected primary colorectal cancers were re-
trieved from the pathology files of the Department of Labo-
ratory Medicine, Shinshu University Hospital, Matsumoto,
Japan. They included 40 patients (22 male and 18 female
with ages ranging from 49 to 85 years (average 66.5 years))
operated on at that hospital. In each patient, a representative
portion of colorectal cancer and its normal counterpart at the
cut end were examined. All tissue samples were fixed in
20% formalin buffered with 0.1 M phosphate buffer (pH
7.4) at room temperature for 48 hr and then embedded in
paraffin. Clinicopathological data analyzed in the present
study were based on the original pathology reports, in which
venous invasion and lymphatic invasion were assessed by
Victoria blue-H&E staining and H&E staining, respectively.
The experimental protocol for this study was approved by
the Ethical Committee of Shinshu University School of
Medicine.
Isolation of RNA from formalin-fixed, paraffin-embedded 
tissue blocks and cDNA synthesis
Total RNA was isolated from tumor portion of colo-
rectal cancer tissues embedded in paraffin blocks. To avoid
possible contamination of surrounding connective tissues or
transitional mucosa from the tumor, the border between
tumor and non-tumor portion was marked on H&E-stained
tissue slides with a marker pen. By referring to the marked
tissue slides, the tumor border was again marked on the
relevant tissue blocks, and shallow incision was then care-
fully made into the tissue blocks using a razor blade along
the marked border. After insection, 6 tissue slices of 5 µm
thickness were prepared and transferred to a sterile 1.5 ml
Fig. 1. Biosynthesis of CS-E. CS-A is converted to CS-E by GalNAc4S-6ST, which catalyzes sulfation at the C6 position of GalNAc(4SO4)
residues of CS-A from a sulfate donor, 3'-phosphoadenosine 5'-phosphosulfate (PAPS). The position of carbon atoms is numbered in italics.GalNAc4S-6ST mRNA in Colorectal Cancer 55
tube. Similarly, total RNA was also prepared from the nor-
mal colorectal mucosa, making another shallow incision be-
tween the mucosal layer and submucosa of paraffin blocks
containing normal colorectal mucosa, and 6 slices of 5 µm
thickness were transferred in the same manner. For deparaf-
finization, 1 ml of Hemo De (FALMA, Tokyo, Japan) was
added to each tube and agitated. Tubes were tilted on a wave
shaker at room temperature for 20 min and then centrifuged
at 20,000×g for 20 min. After centrifugation, the supernatant
was removed immediately and the step repeated 3 times.
Next, 1 ml of 100% ethanol was added to the same tube and
agitated. All tubes were shaken again at room temperature
for 15 min, centrifuged at 20,000×g for 20 min, and immedi-
ately the supernatant was discarded, a step repeated three
times. The pellet was dried completely and dissolved in 50
µl of proteinase K solution containing 1 µg/µl proteinase K
(Nacalai Tesque, Kyoto, Japan), 20 mM Tris-HCl (pH 8.0),
0.15 M NaCl, 5 mM EDTA, and 1% sodium dodecyl sulfate.
Tubes were capped and incubated at 37°C overnight. Total
RNA was isolated using an RNeasy Mini Kit (Qiagen,
Hilden, Germany), according to the manufacturer’s instruc-
tions. To remove genomic DNA, 15 µl of purified total RNA
was digested with 2.5 µl of 10 U/µl RNase-free DNase I
(Roche, Penzberg, Germany) at 37°C for 2 hr and heated at
70°C to inactivate the enzyme. Samples were then denatured
at 70°C for 10 min and hybridized with 1 µl of 0.5 µg/µl
random primers (Promega, Madison, WI, USA). For single-
strand cDNA synthesis, total RNA was reverse transcribed
using 1 µl of 200 U/µl SuperScript III (Invitrogen, Carlsbad,
CA, USA), 2.5 µl of a 2.5 mM dNTP mixture, 0.5 µl of 0.1
M dithiothreitol, and 1 µl of 40 U/µl RNasin Plus RNase in-
hibitor (Promega) at 50°C for 1 hr and then heated to 70°C
for 10 min. First-strand cDNA was used as a template for
real-time RT-PCR.
Real-time RT-PCR analysis of GalNAc4S-6ST mRNA
Real-time RT-PCR analysis of GalNAc4S-6ST mRNA
was achieved by using the 7300 Real-Time PCR system
(Applied Biosystems, Foster City, CA, USA). Premixed
reagents containing primers and TaqMan probes for
GalNAc4S-6ST (Hs00248144_m1) and β2-microglobulin
(B2M) (Hs99999907_m1) as a standard housekeeping gene
were purchased from Applied Biosystems. To construct a
standard curve, regions amplified using premixed primers
for GalNAc4S-6ST or B2M were cloned into the pGEM-T
vector (Promega), and a 10-fold dilution series of plasmid
DNA ranging from 100 ag/µl to 1 pg/µl together with
50 ag/µl concentration of the same plasmid DNA were
measured.
Using 96-well optical plates, a 50 µl solution contain-
ing 25 µl of 2×TaqMan universal master mix (Applied Bio-
systems), 0.5 µl of cDNA, and 2.5 µl of premixed reagents
containing primers and TaqMan probe were added to each
well. Plates were heated to 50°C for 2 min and 95°C for 10
min and then subjected to 55 thermal cycles (95°C for 15
sec, 60°C for 1 min). Absence of genomic DNA contamina-
tion was confirmed by amplifying samples without reverse
transcriptase. GalNAc4S-6ST mRNA expression was nor-
malized to that of B2M mRNA of the corresponding sam-
ple. Relative expression of GalNAc4S-6ST was defined by
GalNAc4S-6ST mRNA/B2M mRNA ratios multiplied by
1×103. Assays were performed in duplicate, and median
value and 25–75 percentile were indicated.
Preparation of a GalNAc4S-6ST-specific RNA probe for ISH
A digoxigenin (DIG)-labeled RNA probe was used
to detect GalNAc4S-6ST mRNA in colorectal cancer by
ISH. Using pFLAGGalNAc4S-6ST as a template [20], a
GalNAc4S-6ST-specific nucleotide sequence (nucleotides
801–950; the first nucleotide of the initiation codon is de-
fined as 1) was amplified by PCR. According to the pub-
lished sequence (DDBJ/EMBL/GenBank accession number
AB062423), 5'- and 3'-primers were 5'-CCCAAGCTTAG-
ACCTCTATGACCGCCTGC-3' and 5'-GGAATTCAAGA-
GGTCCAGATAATCTTCC-3', respectively (HindIII and
EcoRI sites underlined). Amplified DNA was cloned into
HindIII and EcoRI sites of pGEM-3Zf (+) (Promega), and
the resultant vector was used as a template to construct
the probe, after confirming the correct sequence using an
ABI3100 DNA sequencer (Applied Biosystems). A DIG-
labeled antisense RNA probe was obtained from HindIII-
cut template and T7 RNA polymerase with a DIG RNA
Labeling Mixture (Roche), as described [18]. Similarly,
control sense probes were generated using EcoRI-cut tem-
plate and SP6 RNA polymerase. Linearized probes were
precipitated with LiCl-ethanol, dissolved in DEPC-water,
and stored at –80°C until use.
ISH
Hybridization and detection of the probes were carried
out as described [12, 18]. Briefly, 7 µm-thick tissue sections
prepared from the same tissue blocks containing colorectal
cancer analyzed by real-time RT-PCR were deparaffinized
in Hemo De (FALMA), hydrated with ethanol, neutralized
with 0.2 M HCl for 20 min, treated with 50 µg/ml proteinase
K (Amresco, Solon, OH, USA) at 37°C for 30 min, and then
postfixed with 4% paraformaldehyde. Tissue slides were
rinsed in 0.2% glycine for quenching and acetylated with
0.25% acetic anhydride in 0.1 M triethanolamine (pH 8.0).
Hydrated slides were defatted with chloroform and air-dried.
Sections were prehybridized with 50% deionized forma-
mide/2×SSC at 45°C for 1 hr and then hybridized with 1
µg/ml of GalNAc4S-6ST antisense or sense probe in 50%
deionized formamide, 2.5 mM EDTA (pH 8.0), 0.3 M NaCl,
1×Denhardt’s solution, 10% dextran sulfate, and 1 mg/ml
brewer’s yeast tRNA at 45°C for 36 hr.
After hybridization, slides were washed in 50% forma-
mide/2×SSC for 1 hr at 45°C and digested with 10 µg/ml
RNase A (Amresco) in RNase buffer (0.5 M NaCl, 10 mM
Tris-HCl) at 37°C for 30 min, followed by washing in
50% formamide/2×SSC at 37°C for 1 hr and then in 50%
formamide/1×SSC at 37°C for 1 hr. After washing, sections
were subjected to immunohistochemistry to detect hybrid-
ized probes with an alkaline phosphatase-conjugated anti-Ito et al. 56
DIG antibody (Roche). The alkaline phosphatase reaction
was carried out with 5-bromo-4-chloro-3-indolyl phosphate
and nitroblue tetrazolium in the presence of 10% polyvinyl
alcohol at 4°C overnight. Sense probe controls showed no
specific reactivity.
Statistical analysis
Statistical analysis was carried out using JMP 6 soft-
ware (SAS, Cary, NC, USA). Significance with non-para-
metric distribution was evaluated by the Mann-Whitney U
test for unpaired observations. Comparison of more than
two groups was analyzed using the Kruskal-Wallis test. P
values <0.05 were considered to be statistically significant.
III. Results
Expression levels of GalNAc4S-6ST mRNA determined by 
real-time RT-PCR
GalNAc4S-6ST mRNA expression levels in formalin-
fixed and paraffin-embedded sections of colorectal cancer
tissues from 40 patients and normal counterparts were deter-
mined using real-time RT-PCR. Based on the standard curve
for B2M, amounts of the reverse-transcribed B2M cDNA in
the samples were found ranging from 1.43 fg to 947.95 fg
(median (25–75 percentile)=91.38 (43.73–139.90)), indicat-
ing that RNA retention in the tissue blocks was variable.
GalNAc4S-6ST transcripts were expressed at a much lower
level than B2M transcripts, whether from cancer or normal
mucosa, consistent with previous observations that glyco-
gene expression is generally low [3]. The expression level
of GalNAc4S-6ST mRNA in cancer tissues normalized by
B2M, which was defined by GalNAc4S-6ST mRNA/B2M
mRNA ratios multiplied by 1×103, ranged from 0.80 to
709.68 (6.30 (2.85–14.68)), while that in normal mucosa
ranged from 2.50 to 802.10 (6.29 (4.78–7.59)). When com-
pared to paired normal colorectal mucosa, up- and down-
regulations of GalNAc4S-6ST in cancer tissues were found
in 57.5% and 42.5% of the patients, respectively (Fig. 2).
Detection of GalNAc4S-6ST mRNA in colorectal cancer cells 
by ISH
Analysis using real-time RT-PCR cannot determine
which cell type(s) express GalNAc4S-6ST mRNA in cancer
tissues. Thus, cancer tissues from 27 patients randomly
selected from among the 40 patients analyzed by real-time
RT-PCR were also examined by ISH using a DIG-labeled
GalNAc4S-6ST RNA probe. Because the signal intensity for
GalNAc4S-6ST mRNA was generally low, we classified the
ISH results into 2 categories, “positive” or “negative”. The
“positive” result was defined only when the signals were
detected in the cytoplasm of cells using the antisense probe,
regardless of the signal intensity. Accordingly 5 patients
were excluded from the evaluation because nuclear staining
was found in the tissue specimens. Based on the criteria,
the positive signals for GalNAc4S-6ST were detected in
colorectal cancer cells in 12 patients, whereas such signals
were not seen in the remaining 10 (Fig. 3). Other cells such
as stromal cells and inflammatory cells were negative for
GalNAc4S-6ST mRNA. When expression of GalNAc4S-
6ST mRNA determined by real-time RT-PCR in cancer
tissues was compared between patients positive or negative
for GalNAc4S-6ST mRNA based on ISH analysis, expres-
sion of GalNAc4S-6ST mRNA was significantly higher in
positive compared to negative patients (P<0.05) (Fig. 4),
indicating the validity of the real-time RT-PCR assay for
GalNAc4S-6ST mRNA using archived tissue sections.
These data establish that GalNAc4S-6ST is transcribed
by colorectal cancer cells and that real-time RT-PCR
combined with ISH is a useful technique to investigate
GalNAc4S-6ST mRNA expression quantitatively in forma-
lin-fixed and paraffin-embedded tissue sections.
Clinicopathological significance of GalNAc4S-6ST mRNA on 
tumor progression
CS-E is a known to have high affinity to P-selectin
[11]. Thus, it was possible that GalNAc4S-6ST expressed
by colorectal cancer cells was associated with tumor pro-
gression. To test this hypothesis, a retrospective analysis
was carried out to determine the relationship between
GalNAc4S-6ST expression in colorectal cancer tissues as
determined by real-time RT-PCR and clinicopathological
Fig. 2. Comparison of expression levels of GalNAc4S-6ST mRNA
between cancer and paired normal colorectal mucosa tissue in 40
patients with colorectal cancer. GalNAc4S-6ST expression was
determined by real-time RT-PCR using archived tissue blocks, and
the expression level of GalNAc4S-6ST was defined by GalNAc4S-
6ST/B2M ratios multiplied by 1×103. Y-axis indicates logarithmic
scale.GalNAc4S-6ST mRNA in Colorectal Cancer 57
variables such as histopathology of tumor, depth of inva-
sion, and tumor stage. Among the variables examined,
GalNAc4S-6ST was most positively associated with lym-
phatic vessel invasion and venous invasion of tumor
cells, but this relationship was not statistically significant
(P=0.125 for lymphatic vessel invasion; P=0.242 for venous
invasion) (Table 1). P values of other valuables such as
tumor stage were greater than 0.3. These results suggest
that GalNAc4S-6ST plays a minor role in progression of
colorectal cancer.
IV. Discussion
GalNAc4S-6ST is a key sulfotransferase functioning
in the biosynthesis of CS-E, a highly sulfated form of CS.
GalNAc4S-6ST was originally purified from squid cartilage
[9], and cDNA encoding human GalNAc4S-6ST has been
cloned [20]. Although CS-E plays important roles in various
biological events [2], the expression profile of GalNAc4S-
6ST mRNA in tumors has not been reported. Here for
the first time, we analyzed expression of GalNAc4S-6ST
mRNA in colorectal cancer tissues using archived formalin-
fixed and paraffin-embedded tissue blocks, combining both
quantitative real-time RT-PCR and ISH. Our studies reveal
that GalNAc4S-6ST is transcribed in colorectal cancer cells
at a low but significant level. These results indicate that
combining these techniques can detect mRNA of glyco-
genes, which are generally transcribed at low levels, in tis-
sue sections prepared in this manner. Since GalNAc4S-6ST
mRNA is also detected in some colon cancer cell lines, such
as Caco2, SW480, and Colo26 (Ito and Nakayama, personal
communication), the role of GalNAc4S-6ST expressed by
colorectal cancer is of great interest. In addition, it is also
noteworthy that the expression level of GalNAc4S-6ST
mRNA in normal colorectal mucosa is restricted to a narrow
range, whereas that in colorectal cancer tissues is apparently
distributed diversely, indicating that the GalNAc4S-6ST
gene is variably transcribed in malignant cells. It would be
important to reveal the mechanism how the GalNAc4S-6ST
gene is regulated in the tumor.
In the present study, we have clearly shown that
GalNAc4S-6ST is transcribed in normal colorectal mucosa
by using quantitative RT-PCR (see Fig. 2). Because our pre-
liminary study using ISH indicated that GalNAc4S-6ST was
transcribed in absorptive cells and goblet cells located in the
lower portion of normal colorectal mucosa (unpublished
results), it will be of great significance to determine the
physiological role(s) of GalNAc4S-6ST in these cells.
Fig. 3. Detection of GalNAc4S-6ST mRNA in colorectal cancer cells by ISH. Positive GalNAc4S-6ST mRNA signals detected in cancer cells in
which GalNAc4S-6ST mRNA expression as determined by real-time RT-PCR assay was high (GalNAc4S-6ST/B2M×103=228.28) (A). By
contrast, GalNAc4S-6ST mRNA is not detectable in cancer cells in which expression of GalNAc4S-6ST mRNA was low (GalNAc4S-6ST/
B2M×103=2.843) (C). A and C; antisense probe. B and D; sense probe. Bar=100 µm. (×400)Ito et al. 58
For ISH, an RNA probe covering the entire coding re-
gion of a cDNA can be utilized after limited alkaline degra-
dation. However, it is well known that some glycogenes
show a structural relationship in having different functions
as found in the case of GalNAc4S-6ST and heparin sulfate
3-O-sulfotransferase 1 (3OST-1) [20]. To avoid cross-hy-
bridization with 3OST-1 or other related sulfotransferases,
we designed the RNA probe to hybridize with a short seg-
ment (150 bp) of the cDNA, specific for GalNAc4S-6ST.
Indeed, significant homology was not seen between the
RNA probe for GalNAc4S-6ST used in this study and other
related genes. We showed here that a significant associa-
tion is present between the results of real-time RT-PCR and
those of ISH, indicating that the positive signal detected by
ISH should represent GalNAc4S-6ST mRNA itself.
Our results of ISH were negative in 5 patients even
though the expression level of GalNAc4S-6ST mRNA was
higher than the lowest expression level of this transcript
found in the patients positive for ISH (see Fig. 4). In the
present study, the length of the nucleotide sequence of
GalNAc4S-6ST detected by ISH was 150 base pairs, while
that detected by the real-time RT-PCR assay was 72 base
pairs. Thus, it might be possible that limited degradation of
mRNA occurred in the tissue blocks during preservation
would work against ISH rather than real-time RT-PCR,
because ISH required longer nucleotide sequence than real-
time RT-PCR.
In the present study, we found that GalNAc4S-6ST
mRNA was expressed in colorectal cancer cells. Recently,
Kawashima et al. reported that CS-E units could bind to P-
selectin with high affinity [11]. In addition, CS-E units in-
hibited P-selectin binding to a human breast cancer cell line
[17]. Those reports indicate that CS-E may serve as a P-se-
lectin ligand. Thus it is possible that CS-E on the tumor cells
facilitate the metastasis by binding to P-selectin expressed in
the endothelial cells and/or platelets. In addition, it is also
likely that the negative charge of CS-E may attenuate the ad-
hesion of tumor cells, thus allowing them to migrate from
Fig. 4. Association between expression levels of GalNAc4S-6ST
mRNA and results obtained by ISH. Expression of GalNAc4S-6ST
mRNA is significantly increased in patients positive for ISH (n=10)
compared with patients negative for ISH (n=12) (P<0.05). The
expression level of GalNAc4S-6ST was defined by GalNAc4S-6ST/
B2M ratios multiplied by 1×103. Vertical bars indicate median and
25–75 percentiles, and Y-axis indicates logarithmic scale.
Table 1. Comparison of expression levels of GalNAc4S-6ST mRNA
with colorectal cancer according to clinicopathological parameters
a GalNAc4S-6ST/B2M mRNA ratios multiplied by 1×103 are indi-
cated as median (25–75 percentile).
b “Proximal” includes cecum, ascending colon, and transverse
colon; “distal” includes descending colon, sigmoid colon, and rec-
tum.
c Well: well differentiated adenocarcinoma; moderate: moderately
differentiated adenocarcinoma; poor: poorly differentiated adeno-
carcinoma.
d sm, submucosa; mp, muscularis propria; ss, subserosa; se, expo-
sure on serosa; si, invasion to neighboring tissue; a, adventitia.
e A, confined to the intestinal wall; B, complete penetration of the
intestinal wall; C, presence of nodal involvement; D, presence of
distant metastasis.
f Analyzed by Mann-Whitney U test.
g Analyzed by Kruskal-Wallis test.
Parameters Patients GalNAc4S-6STa P value
Locationb
Proximal 15 5.73 (2.62–13.64) 0.349f
Distal 25 7.04 (3.46–16.37)
Histopathologyc
Well 27 5.77 (2.84–13.76) 0.305f
Moderate and poor 13 7.76 (3.89–17.36)
Depth of invasiond
sm and mp 9 7.76 (1.94–17.69) 0.961f
ss, se, si, and a 31 6.25 (2.89–14.15)
Duke’s classificatione
A 4 1.94 (1.00–13.80) 0.334g
B 11 5.77 (3.39–15.76)
C 11 6.48 (2.62–13.76)
D 14 7.18 (4.49–15.39)
Lymph node metastasis
Negative 20 6.01 (2.98–15.36) 0.871f
Positive 20 6.42 (2.80–14.58)
Lymphatic vessel invasion
Negative 4 2.50 (1.00–12.67) 0.125f
Positive 36 6.42 (3.05–14.68)
Venous invasion
Negative 1 17.64 (17.64–17.64) 0.242f
Positive 39 6.25 (2.84–14.15)GalNAc4S-6ST mRNA in Colorectal Cancer 59
the primary site, similar to polysialic acid expression in non-
small cell lung cancer [24] and astrocytoma [23]. To deter-
mine if any relationship is present between the expression
of GalANc4S-6ST and progression of colorectal cancer,
we compared the expression level of GalNAc4S-6ST in
the cancer tissue with clinicopathological variables, since
GalNAc4S-6ST is a key enzyme required to form CS-E.
However, GalNAc4S-6ST expression was only slightly as-
sociated with vessel invasion. Previously we showed that
sialyl Lea [Siaα2,3Galβ1,3(Fucα1,4)GlcNAcβ1→R] and
sialyl Lex [Siaα2,3Galβ1,4(Fucα1,3)GlcNAcβ1→R] on
core2-branched  O-glycans displayed on the surface of
colorectal cancer cells, an established ligand for E- and P-
selectins, was significantly correlated with vessel invasion
[22]. These results combined together indicate that CS-E
plays a role in tumor progression of colorectal cancer, but
its effects are more minor than those of sialyl Lea and sialyl
Lex expressed on core2-branched O-glycans. Further study
is needed to establish the effects of CS-E on the tumor pro-
gression with a larger number of colorectal cancer patients.
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